AZD8835
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD8835, covering 2016-10-10 to 2016-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours [Phase 1]